TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effect of Adductor-Canal-Block (ACB) in Patients After Anterior Cruciate Ligament (ACL) Reconstruction in Day Case Surgery
Brief Summary: The Purpose of this study is to determine whether Adductor-Canal-Block is superior to placebo when it comes to analgetic efficacy after reconstruction of the anterior cruciate ligament.


Options:
A: Arm Label: Adductor Canal Block:; Type: EXPERIMENTAL; Interventions: Procedure: Adductor Canal Block, Bupivacaine | Arm Label: Femoral Nerve Block; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Femoral Nerve Block, Bupivacaine | Intervention Type: PROCEDURE; Name: Adductor Canal Block, Bupivacaine; Assigned to Arm(s): Adductor Canal Block: | Intervention Type: PROCEDURE; Name: Femoral Nerve Block, Bupivacaine; Assigned to Arm(s): Femoral Nerve Block
B: Arm Label: Adductor-Canal-Block, Ropivacain; Type: EXPERIMENTAL; Interventions: Procedure: Ropivacain | Arm Label: Adductor Canal Block, Placebo (saline); Type: PLACEBO_COMPARATOR; Interventions: Procedure: Saline | Intervention Type: PROCEDURE; Name: Ropivacain; Assigned to Arm(s): Adductor-Canal-Block, Ropivacain | Intervention Type: PROCEDURE; Name: Saline; Assigned to Arm(s): Adductor Canal Block, Placebo (saline)
C: Arm Label: Adductor-Canal-Blockade; Type: EXPERIMENTAL; Interventions: Procedure: Adductor-Canal-Blockade | Arm Label: Femoral Nerve Block; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Femoral Nerve Block | Intervention Type: PROCEDURE; Name: Adductor-Canal-Blockade; Assigned to Arm(s): Adductor-Canal-Blockade | Intervention Type: PROCEDURE; Name: Femoral Nerve Block; Assigned to Arm(s): Femoral Nerve Block
D: Arm Label: Adductor-Canal-Blockade; Type: EXPERIMENTAL; Interventions: Procedure: Adductor-Canal-Blockade | Arm Label: Adductor-Canal-blockade with saline; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Adductor-Canal-blockade with saline | Intervention Type: PROCEDURE; Name: Adductor-Canal-Blockade; Assigned to Arm(s): Adductor-Canal-Blockade | Intervention Type: PROCEDURE; Name: Adductor-Canal-blockade with saline; Assigned to Arm(s): Adductor-Canal-blockade with saline

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Safety and Feasibility Study of High Dose Left Prefrontal Transcranial Magnetic Stimulation (TMS) to Rapidly Stabilize Suicidal Patients With PTSD
Brief Summary: The purpose of this study is to determine whether transcranial magnetic stimulation (TMS) is effective in the treatment of suicidal thinking in individuals with a depressive episode and either posttraumatic stress disorder (PTSD), history of mild traumatic brain injury (TBI), or both conditions.


Options:
A: Arm Label: Intervention Group ASSIP; Type: EXPERIMENTAL; Interventions: Behavioral: Attempted Suicide Short Intervention Program (ASSIP) | Arm Label: Control Group CG; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Control Group (CG) | Intervention Type: BEHAVIORAL; Name: Attempted Suicide Short Intervention Program (ASSIP); Assigned to Arm(s): Intervention Group ASSIP | Intervention Type: BEHAVIORAL; Name: Control Group (CG); Assigned to Arm(s): Control Group CG
B: Arm Label: TMS; Type: EXPERIMENTAL; Interventions: Device: Transcranial Magnetic Stimulation | Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Transcranial Magnetic Stimulation - Sham Comparator | Intervention Type: DEVICE; Name: Transcranial Magnetic Stimulation; Assigned to Arm(s): TMS | Intervention Type: DEVICE; Name: Transcranial Magnetic Stimulation - Sham Comparator; Assigned to Arm(s): Sham
C: Arm Label: Case management; Type: EXPERIMENTAL; Interventions: Behavioral: Case management | Arm Label: Enhanced usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Enhanced usual care | Intervention Type: BEHAVIORAL; Name: Case management; Assigned to Arm(s): Case management | Intervention Type: OTHER; Name: Enhanced usual care; Assigned to Arm(s): Enhanced usual care
D: Arm Label: Experimental Arm; Type: EXPERIMENTAL; Interventions: Other: Other | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Other; Assigned to Arm(s): Experimental Arm

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The Örebro prevention program is a brief (6 x 30 minutes)program administered to parents of 13-16 year old youths in regular parental meetings. The program aims to encourage parents to maintain a restrictive attitude towards youth drinking throughout their children's teenage years, and thereby postpone and reduce youth drinking. A previous quasi-experimental study by the program developers showed a sustained alcohol-specific restrictivity among parents exposed to the program, and also a reduction on drinking measures among the youths of the exposed parents (Koutakis, Stattin \& Kerr, 2008). This study aims to investigate whether these effects are sustained also when the program has gone into wide dissemination in Sweden.


Options:
A: Arm Label: 1) MI/Family Check-Up; Type: EXPERIMENTAL; Interventions: Behavioral: MI/Family Check-up | Arm Label: 2) MI only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: MI only | Intervention Type: BEHAVIORAL; Name: MI/Family Check-up; Assigned to Arm(s): 1) MI/Family Check-Up | Intervention Type: BEHAVIORAL; Name: MI only; Assigned to Arm(s): 2) MI only
B: Arm Label: Intervention Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Family-Skills Training | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Family-Skills Training | Intervention Type: BEHAVIORAL; Name: Family-Skills Training; Assigned to Arm(s): Control Group, Intervention Group
C: Arm Label: Örebro prevention program; Type: EXPERIMENTAL; Interventions: Behavioral: Örebro prevention program | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Business as usual | Intervention Type: BEHAVIORAL; Name: Örebro prevention program; Assigned to Arm(s): Örebro prevention program | Intervention Type: BEHAVIORAL; Name: Business as usual; Assigned to Arm(s): Control
D: Arm Label: Mother Program; Type: EXPERIMENTAL; Interventions: Behavioral: New Beginnings Program | Arm Label: Mother Plus Child Program; Type: EXPERIMENTAL; Interventions: Behavioral: New Beginnings Program | Arm Label: Literature Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: New Beginnings Program; Assigned to Arm(s): Mother Plus Child Program, Mother Program

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective Randomised Controlled Study to Investigate the Effectiveness of Using a Quality of Life Questionnaire to Target Interventions to Improve Quality of Life in Patients With Lung Cancer
Brief Summary: This study will investigate the effectiveness of using the European Organisation for Research and Treatment of cancer Core Quality of Life Questionnaire (EORTC QLQ-C30 + LC 13) to identify and target therapies in patients with lung cancer. The study will assess whether using the questionnaire will result in an improvement in QoL.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Intervention | Arm Label: Attention; Type: EXPERIMENTAL; Interventions: Other: Attention | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Control | Intervention Type: OTHER; Name: Intervention; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Attention; Assigned to Arm(s): Attention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
B: Arm Label: Usual Care Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual psychosocial support | Arm Label: DT&PL arm; Type: EXPERIMENTAL; Interventions: Behavioral: Distress Thermometer and Problems List | Intervention Type: BEHAVIORAL; Name: Distress Thermometer and Problems List; Assigned to Arm(s): DT&PL arm | Intervention Type: BEHAVIORAL; Name: Usual psychosocial support; Assigned to Arm(s): Usual Care Arm
C: Arm Label: intervention group; Type: ACTIVE_COMPARATOR; Interventions: Device: distress thermometer | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: distress thermometer; Assigned to Arm(s): intervention group
D: Arm Label: Intervention group 1; Type: EXPERIMENTAL; Interventions: Other: Questionnaire administration | Arm Label: Intervention group 2; Type: EXPERIMENTAL; Interventions: Other: Questionnaire administration | Arm Label: Control group 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control group 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Questionnaire administration; Assigned to Arm(s): Intervention group 1, Intervention group 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective Randomised Controlled Study to Investigate the Effectiveness of Using a Quality of Life Questionnaire to Target Interventions to Improve Quality of Life in Patients With Lung Cancer
Brief Summary: This study will investigate the effectiveness of using the European Organisation for Research and Treatment of cancer Core Quality of Life Questionnaire (EORTC QLQ-C30 + LC 13) to identify and target therapies in patients with lung cancer. The study will assess whether using the questionnaire will result in an improvement in QoL.


Options:
A: Arm Label: Structured patient visits; Type: OTHER; Interventions: Behavioral: Structured patient-centered follow up of depression | Arm Label: Treatment as usual; Type: OTHER; Interventions: Behavioral: Structured patient-centered follow up of depression | Intervention Type: BEHAVIORAL; Name: Structured patient-centered follow up of depression; Assigned to Arm(s): Structured patient visits, Treatment as usual
B: Arm Label: Hearing Aid Fitting Order A; Type: ACTIVE_COMPARATOR; Interventions: Device: Hearing Aid Fitting A, Device: Hearing Aid Fitting B | Arm Label: Hearing Aid Fitting Order B; Type: ACTIVE_COMPARATOR; Interventions: Device: Hearing Aid Fitting A, Device: Hearing Aid Fitting B | Intervention Type: DEVICE; Name: Hearing Aid Fitting A; Assigned to Arm(s): Hearing Aid Fitting Order A, Hearing Aid Fitting Order B | Intervention Type: DEVICE; Name: Hearing Aid Fitting B; Assigned to Arm(s): Hearing Aid Fitting Order A, Hearing Aid Fitting Order B
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Intervention | Arm Label: Attention; Type: EXPERIMENTAL; Interventions: Other: Attention | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Control | Intervention Type: OTHER; Name: Intervention; Assigned to Arm(s): Intervention | Intervention Type: OTHER; Name: Attention; Assigned to Arm(s): Attention | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control
D: Arm Label: Implementation intervention; Type: EXPERIMENTAL; Interventions: Other: Implementation intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Implementation intervention; Assigned to Arm(s): Implementation intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multifaceted Nurse-based Strategy Reduces HEart FaiLure Morbidity in PatiENts Admitted for Acute Decompensated Heart Failure in Brazil
Brief Summary: The home based intervention is a multidisciplinary approach that has shown benefit in the follow-up of patients with Heart Failure (HF). It is considered one of the most effective approaches and humanized by education and care for the patient in his environment of routine. In this study the monitoring of HF patients in the home after hospital discharge will include the reinforcement, monitoring and reassessment of previously provided guidance on the disease and self-care, compliance to prescribed medications and especially the early recognition of signs and symptoms of decompensation by patients and their caregivers.


Options:
A: Arm Label: Intervention; Type: ACTIVE_COMPARATOR; Interventions: Other: Education | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Education; Assigned to Arm(s): Intervention
B: Arm Label: Experimental: Intervention and control; Type: EXPERIMENTAL; Interventions: Behavioral: Home based education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Home based education; Assigned to Arm(s): Experimental: Intervention and control
C: Arm Label: Enhanced Usual Care (EUC) exercise group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care Group | Arm Label: HEART Camp (HC) Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: HEART Camp (HC) Intervention Group | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care Group; Assigned to Arm(s): Enhanced Usual Care (EUC) exercise group | Intervention Type: BEHAVIORAL; Name: HEART Camp (HC) Intervention Group; Assigned to Arm(s): HEART Camp (HC) Intervention group
D: Arm Label: Family-Centered Empowerment Model; Type: EXPERIMENTAL; Interventions: Other: Family-centered empowerment model | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Control | Intervention Type: OTHER; Name: Family-centered empowerment model; Assigned to Arm(s): Family-Centered Empowerment Model | Intervention Type: OTHER; Name: Control; Assigned to Arm(s): Control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intracervical Two Percent Lidocaine Gel as an Analgesic During Intrauterine Device Insertion: A Randomized Controlled Trial
Brief Summary: The intrauterine device (IUD) is a form of birth control that is extremely effective and safe, even in women who have not yet had children. Women can experience high levels of pain when the IUD is placed inside the uterus, and fear of this pain could be a reason that women decide not to use this method.

This study will randomly (like flipping a coin) assign women who have chosen the IUD as their contraceptive into two groups. One group will have lidocaine anesthetic gel placed into their cervix prior to having the IUD inserted; the other will have an inert gel placed into their cervix instead. The level of pain at three different time points on a 10cm scale and the patient's satisfaction with the procedure will be compared between the two groups to see if using lidocaine gel helps decrease IUD insertional pain


Options:
A: Arm Label: Misoprostol; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Magnesium Oxide | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol | Intervention Type: DIETARY_SUPPLEMENT; Name: Magnesium Oxide; Assigned to Arm(s): Placebo
B: Arm Label: Group 1: Intravaginal 2% lidocaine gel; Type: EXPERIMENTAL; Interventions: Drug: Lidocaine | Arm Label: Group 2: Intravaginal placebo gel; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Lidocaine; Assigned to Arm(s): Group 1: Intravaginal 2% lidocaine gel | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Group 2: Intravaginal placebo gel
C: Arm Label: lidocaine gel; Type: EXPERIMENTAL; Interventions: Drug: 2% lidocaine gel | Arm Label: placebo gel (surgilube); Type: PLACEBO_COMPARATOR; Interventions: Other: placebo | Intervention Type: DRUG; Name: 2% lidocaine gel; Assigned to Arm(s): lidocaine gel | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): placebo gel (surgilube)
D: Arm Label: Control Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo gel | Arm Label: Study Group; Type: EXPERIMENTAL; Interventions: Drug: 2% lidocaine gel | Intervention Type: DRUG; Name: 2% lidocaine gel; Assigned to Arm(s): Study Group | Intervention Type: DRUG; Name: Placebo gel; Assigned to Arm(s): Control Group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of the Survival Benefit of the Adjunction of Pentoxifylline to Corticosteroids in Patients Suffering From Severe Alcoholic Hepatitis
Brief Summary: The treatment of severe forms of alcoholic hepatitis (AH) constitutes a major challenge for clinicians involved in the management of severe alcoholic liver disease. In patients with Maddrey function higher than 32, compelling evidence from data has shown that corticosteroids improve short-term survival. However, novel strategies or molecules are required in light of the fact that approximately 40 % of patients continue to die at 6 months. A double-blinded randomized controlled trial of 101 patients has showed that Pentoxifylline improves survival of patients with severe AH, as compared to placebo. In terms of mechanisms, the effect of pentoxifylline is related to prevention of hepatorenal function whereas corticosteroids induce an early improvement in liver function. When considering these differences of mechanisms, many clinicians suggest that the addition of pentoxyfilline to corticosteroids is an attractive option that needs to be tested in patients with severe AH.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: pentoxifylline | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: PLACEBO | Intervention Type: DRUG; Name: pentoxifylline; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: PLACEBO; Assigned to Arm(s): 2
B: Arm Label: Pentoxifylline + Prednisolone; Type: ACTIVE_COMPARATOR; Interventions: Drug: placebo | Arm Label: Placebo + Prednisolone; Type: PLACEBO_COMPARATOR; Interventions: Drug: Pentoxifylline | Intervention Type: DRUG; Name: Pentoxifylline; Assigned to Arm(s): Placebo + Prednisolone | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Pentoxifylline + Prednisolone
C: Arm Label: Corticoids plus N Acetyl Cysteine; Type: EXPERIMENTAL; Interventions: Drug: Corticoids plus N Acetyl Cysteine | Intervention Type: DRUG; Name: Corticoids plus N Acetyl Cysteine; Assigned to Arm(s): Corticoids plus N Acetyl Cysteine
D: Arm Label: Prednisone; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Pentoxifylline; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Prednisone plus metadoxine; Type: EXPERIMENTAL; Interventions: Drug: Prednisone plus Metadoxine | Arm Label: Pentoxifylline plus metadoxine; Type: EXPERIMENTAL; Interventions: Drug: Pentoxifylline plus Metadoxine | Intervention Type: DRUG; Name: Prednisone plus Metadoxine; Assigned to Arm(s): Prednisone plus metadoxine | Intervention Type: DRUG; Name: Pentoxifylline plus Metadoxine; Assigned to Arm(s): Pentoxifylline plus metadoxine

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assessing the Effect of Improved Rural Sanitation on Diarrhoea and Intestinal Nematode Infections: a Cluster Randomised Controlled Trial in Orissa, India
Brief Summary: The study is a cluster-randomized, controlled trial conducted among 100 villages (including approximately 3500 households and 20,000 people) in Puri district, State of Orissa, India. The study aims to assess the impact of the construction and use of latrines in rural settings on diarrhoeal disease, helminth infections and nutritional status. The study will also report on the cost and cost-effectiveness of the intervention and its impact on lost days at school and work as well as on expenditures on drugs and medical treatment. The study will document how the intervention actually impacts exposure to human excreta along principal transmission pathways by evaluating the impact on (i) faecal contamination of drinking water, (ii) the presence of mechanical vectors (flies) in food preparation areas, and (iii) the presence of faeces in and around participating households and villages. The study will also explore the extent to which different levels of acquisition and use of on-site sanitation among householders impact disease throughout the community.


Options:
A: Arm Label: Sanitation intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Provision of household latrines | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Provision of household latrines; Assigned to Arm(s): Sanitation intervention
B: Arm Label: RANAS; Type: EXPERIMENTAL; Interventions: Other: Hardware, Behavioral: CLTS, Behavioral: PHAST, Behavioral: RANAS | Arm Label: Mini-RANAS; Type: EXPERIMENTAL; Interventions: Other: Hardware, Behavioral: CLTS, Behavioral: PHAST, Behavioral: mini-RANAS | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Hardware, Behavioral: CLTS, Behavioral: PHAST, Other: Placebo poster | Intervention Type: OTHER; Name: Hardware; Assigned to Arm(s): Control, Mini-RANAS, RANAS | Intervention Type: BEHAVIORAL; Name: CLTS; Assigned to Arm(s): Control, Mini-RANAS, RANAS | Intervention Type: BEHAVIORAL; Name: PHAST; Assigned to Arm(s): Control, Mini-RANAS, RANAS | Intervention Type: BEHAVIORAL; Name: RANAS; Assigned to Arm(s): RANAS | Intervention Type: BEHAVIORAL; Name: mini-RANAS; Assigned to Arm(s): Mini-RANAS | Intervention Type: OTHER; Name: Placebo poster; Assigned to Arm(s): Control
C: Arm Label: Intervention group; Type: N/A; Interventions: Behavioral: Improved water supply and sanitation | Arm Label: Control group; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Improved water supply and sanitation; Assigned to Arm(s): Intervention group
D: Arm Label: CLTS communities; Type: EXPERIMENTAL; Interventions: Other: CLTS | Arm Label: Rural communities; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: CLTS; Assigned to Arm(s): CLTS communities

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: The research objectives are to test the efficacy of a Modified CIMT treatment in babies diagnosed with hemiplegia, treated in a home program, as compared to a control group of babies receiving a parallel home program but with no CIMT.


Options:
A: Arm Label: Treatment dosage levels examined; Type: EXPERIMENTAL; Interventions: Other: Therapy services (ACQUIREc Therapy) | Intervention Type: OTHER; Name: Therapy services (ACQUIREc Therapy); Assigned to Arm(s): Treatment dosage levels examined
B: Arm Label: Constraint-induced Movement Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Modified Constraint-induced Movement Therapy | Arm Label: Transditional rehabilitation; Type: OTHER; Interventions: Behavioral: Modified Constraint-induced Movement Therapy | Intervention Type: BEHAVIORAL; Name: Modified Constraint-induced Movement Therapy; Assigned to Arm(s): Constraint-induced Movement Therapy, Transditional rehabilitation
C: Arm Label: Experimental CIMT; Type: EXPERIMENTAL; Interventions: Device: Constraint induced movement therapy (CIMT) | Arm Label: Active Play; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: play | Intervention Type: DEVICE; Name: Constraint induced movement therapy (CIMT); Assigned to Arm(s): Experimental CIMT | Intervention Type: BEHAVIORAL; Name: play; Assigned to Arm(s): Active Play
D: Arm Label: CIMT Intervention; Type: EXPERIMENTAL; Interventions: Procedure: Constraint-Induced Movement Therapy (CIMT) | Arm Label: HABIT Intervention; Type: EXPERIMENTAL; Interventions: Procedure: Hand-Arm Bimanual Intensive Therapy (HABIT) | Intervention Type: PROCEDURE; Name: Constraint-Induced Movement Therapy (CIMT); Assigned to Arm(s): CIMT Intervention | Intervention Type: PROCEDURE; Name: Hand-Arm Bimanual Intensive Therapy (HABIT); Assigned to Arm(s): HABIT Intervention

Answer: C